NLS Insight’s goal is to assist the Nordic regions leading innovators in targeting business collaborations, partnership opportunities and investment potential.

Meet our mentor – Charlotta Falvin!

Ideon Science Park

August 17, 2018

With the Ideon Mentorship Program we want to connect the experienced leaders in the park with entrepreneurs who want to learn how to grow their business. The mentors, the experienced leaders, have serious scale-up skills to teach and important connections to offer to the right mentee. By helping each other they can both grow and who knows – it could be the start of something fantastic! Here’s your chance to get to know one of our fantastic mentors, Charlotta Falvin!

LIVE streaming from Arendal

August 15, 2018

Not in Arendal? Don’t worry, You can see the event right here.

InDex Pharmaceuticals updates timeline for top line results from the CONDUCT study to first half of 2019

InDex Pharmaceuticals

August 13, 2018

InDex Pharmaceuticals Holding AB (publ) today announced an updated timeline for patient recruitment in the ongoing phase IIb study CONDUCT with the drug candidate cobitolimod. Top line results from the study are now expected in the first half of 2019 instead of in the fourth quarter of 2018 as previously communicated.

Promising treatment for late stage cancer

August 10, 2018

MetAction has used targeted gene therapy to give patients with metastatic cancer a treatment method. The future of this work is now in danger.

New report on Norwegian health industry

August 9, 2018

Will the Norwegian health industry become a so-called growth industry? What kind of position can a Norwegian health industry claim internationally?

Finance

Novo Nordisk's operating profit decreased by 8% in Danish kroner and increased by 4% in local currencies in the first six months of 2018

Novo Nordisk

August 9, 2018

Sales decreased by 5% in Danish kroner and increased by 4% in local currencies to USD 8.8 billion.

Meet Us at Arendalsuka

August 1, 2018

In mid-August Oslo Cancer Cluster travel to Arendal to put focus on cancer treatment and innovation.

AbbVie Announces Submission of Supplemental New Drug Application to US FDA for Venetoclax in Newly Diagnosed Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy

AbbVie

July 13, 2018

AbbVie Provides Update on Phase 3 Study of Ibrutinib (IMBRUVICA®) in Blood Cancer Diffuse Large B-Cell Lymphoma (DLBCL) and Ongoing Ibrutinib Clinical Program

AbbVie

July 13, 2018

Ullern Student With a Career in Medicine

July 6, 2018

Aksel Stien graduated from Ullern Secondary School in 2011. Today he is a physician working on his specialty subjects at Oslo University Hospital. Aksel has always wanted to become a physician and the foundation was already in place at Ullern. He learned things from his deployment at The Norwegian Radium Hospital during his upper secondary days that he has yet to learn from his medicine studies.

Meet us at the 11th FENS forum of Neuroscience

Redoxis

July 6, 2018

Francesco Bez will attend the FENS forum of neuroscience taking place in Berlin on the 7-11 of July. We continuously add more models to our portfolio and are looking forward to many new interactions and discussions on how we can assist in your preclinical research.

Sweden is hot right now! A summer greeting from our CEO Mia Rolf

Ideon Science Park

July 2, 2018

The weather in May was extraordinary. Sunny and hot, giving us the feeling that there are no cares in the world. The same goes for the business climate in Sweden. Swedish export companies are working on high steam and in the development sector, our pool of software and IoT competences has never been hotter or more sought after. Yes – there might be a risk the well is drying out, but right now we are all feeling pretty good!